APA (7th ed.) Citation

Zhang DY, Zhu L, Liu HN, Tseng YJ, Weng SQ, Liu TT, . . . Shen XZ. (2019). The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease. Dove Medical Press.

Chicago Style (17th ed.) Citation

Zhang DY, Zhu L, Liu HN, Tseng YJ, Weng SQ, Liu TT, Dong L, and Shen XZ. The Protective Effect and Mechanism of the FXR Agonist Obeticholic Acid via Targeting Gut Microbiota in Non-alcoholic Fatty Liver Disease. Dove Medical Press, 2019.

MLA (9th ed.) Citation

Zhang DY, et al. The Protective Effect and Mechanism of the FXR Agonist Obeticholic Acid via Targeting Gut Microbiota in Non-alcoholic Fatty Liver Disease. Dove Medical Press, 2019.